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INTRODUCTION AND STUDY BACKGROUND 
 
 Epilepsy is one of the most common, serious neurological conditions and around 50 
million people in the world have epilepsy. Imaging plays an important role in the evaluation of 
patients with epilepsy and seizure disorders which have a cortical origin. Structural and 
functional studies including magnetic resonance imaging (MRI), proton magnetic resonance 
spectroscopy (1H MRS), and 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography 
(FDG PET) are used to identify the epileptogenic zone and to confirm the ictal focus based on 
EEG recordings. 
 
Brain metabolites, neurotransmitters and glucose metabolism in epilepsy 
N-acetyl aspartate (NAA), creatine/phosphocreatine (Cr), cholin compounds (Cho) and 
glutamate/glutamine/γ-aminobutyric acid [GABA] complex (Glx) detected by 1H MRS are the 
principal signals of interest in epilepsy studies. NAA is the second most abundant amino acid in 
the human central nervous system, and it appears to exhibit neurotransmitter activity acting on 
glutamate receptors. NAA is localized in mitochondrium fractions and in cytoplasm of the 
neuron, and primarily formed in neurons from acetyl-CoA and aspartate. Cr and Cho are found 
both in neurons and glial cells, but they are present at much higher concentrations in 
oligodendrocytes and astrocytes than in neurons. Creatine is converted to phosphocreatine 
through the enzyme creatine kinase. Phosphocreatine is a high-energy phosphate, which is 
critical for maintaining cellular energy dependent systems. The Cho resonance contains 
contributions from a number of mobile choline compounds. These membrane-bound compounds 
are generally not MR-visible; however, in disease processes which result in membrane 
breakdown the formerly bound cholin is released into free cholin pool and becomes MR-visible.  
Glutamate is the main excitatory neurotransmitter in the human brain and is believed to 
play an important role in the initiation, spread, and maintenance of epileptic activity. Glutamate 
receptors are located on glial and neuronal cells. Increases in the density of NMDA (N-methyl-D-
aspartate), AMPA (α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid), and kainate 
receptors, and increased number of glutamate receptor subunits have been described in epilepsy. 
The functions of glutamate metabotropic and NMDA receptors are modified in epilepsy, and 
alterations in glutamate transporters also potentially can contribute to epileptogenesis. The role of 
glutamate in the mechanism of seizure is supported by antiepileptogenic pharmacological 
compounds which can decrease glutamate release acting on presynaptic terminals, while others, 
used in human practice, reduce the extracellular glutamate concentration by sodium channel 
inactivation. Furthermore, antagonists of NMDA and AMPA receptors are anticonvulsants in 
animal models of epilepsy. 1H MRS detects mainly the intracellular Glx pool (containing 
predominantly glutamate and glutamine), and these are present in both neuronal and in glial cells.  
FDG PET is used to demonstrate the regional cerebral glucose metabolism and it is often 
applied for the localization of epileptogenic brain regions.  Regional hypometabolism identifies 
the epileptogenic lobe in about 80-90 % of children with refractory epilepsy who exhibit focal 
FDG PET abnormalities. In contrast, children with recent-onset epilepsy appear to have less 
frequent and less profound metabolic abnormalities than those with chronic epilepsy. 
 
Relation between N-acetyl compounds (NA) and glutamate/glutamine metabolism  
Similar to NAA, the peptide neurotransmitter N-acetyl aspartyl glutamate (NAAG), a 
derivative of NAA, is also localized in neurons and synthesized from NAA and glutamate. The 
recently identified cellular separation of the two anabolic and two catabolic enzymes in the NAA 
and NAAG cycles points to a three-cell compartmentalization involving neurons (NAA and 
NAAG synthases), astrocytes (NAAG peptidase), and oligodendrocytes (aspartoacyclase). 
NAAG, released by neurons, is cleaved at the cell surface of astrocytes into NAA and glutamate. 
NAA is hydrolyzed in oligodendrocytes, and the end products may serve message to neurons. 
Glutamate is taken up by astrocytes, and it is recycled to neurons via the glutamate-glutamine 
conversion.  
NAAG may have two major roles following the synaptic release: activation of type 3 
metabotropic glutamate receptors, and, based on its rapid turnover, delivery and production of 
glutamate. NAA also shows neurotransmitter activity; however, the relatively slow rate of NAA 
turnover suggests that its major role is as substrate for the formation of NAAG. In pathological 
states, alterations in the levels of NAAG and in the activity of NAAG peptidase have been found 
decreasing or increasing the availability of NAA and glutamate in brain synapses. Both NAA and 
NAAG concentrations can be determined by 1H magnetic resonance spectroscopy (1H MRS) in 
vivo, since the resonance of NA at 2.02 pars per million (ppm) chemical shift value contains 
overlapping resonances including NAA and NAAG.  
 
Coupling between glutamate and glucose metabolism 
A recently articulated hypothesis suggests that the majority of the signal derived from 2-
deoxy-2[F-18]fluoro-glucose uptake measured with PET is due to glutamate stimulation of 
glucose uptake by astrocytes. The hypothesis regarding glutamate and glucose coupling is based 
upon the observation that glutamate stimulated 2-deoxyglucose uptake and phosphorylation by 
astrocytes in primary culture. Further data to support possibly this theory are derived from [C-
13]MRS studies in which cortical rates of oxidative glucose metabolism and glutamate 
neurotransmitter cycling were measured in rats under different degrees of anesthesia. An 
approximate 1:1 stoichiometry was reported between glutamate cycling and glucose metabolism, 
with glutamatergic synaptic activity accounting for over 80% of total glucose oxidation under 
conditions of mild anesthesia. All of the data supporting this hypothesis, however, were derived 
either from cultured astrocytes or anesthetized rodents, and therefore, the applicability of these 
findings to humans remains to be established. 
 STUDY GOALS 
 
The goals of my investigations were:  
1., to detect the altered signal intensity of brain metabolites in the epileptogenic region in the 
unstimulated interictal and stimulated ictal/periictal states in human partial epilepsy patients by 
1H MRS,  
2., to determine the brain glucose utilization in the same cortical regions which were used for 1H 
MRS studies  in the same ictal states using FDG PET,  
3., to investigate the relationship between the cortical tissue concentrations of N-acetyl 
compounds and glutamate/glutamine based on associations between NAAG and glutamate 
neurotransmission,  
4., to test the hypothesis of coupling between glutamate and glucose metabolism in human  
epileptic and non-epileptic cortex by comparing regional values of glucose metabolism from 
FDG PET studies with 1H MRS measurements of Glx tissue concentration. 
 
PATIENTS AND METHODS 
 
Subjects 
 Eleven patients (five females and six males, mean age 7.5 years, age range 0.3-20 years) 
with medically intractable partial epilepsy were included in the study. As part of the presurgical 
evaluation, all patients underwent MRI, quantitative single voxel 1H MRS, FDG PET and 
prolonged video-EEG recordings with scalp and sphenoidal electrodes. Intraoperative 
electrocorticography was performed in two patients, and three patients underwent chronic 
intracranial EEG monitoring. Ictal EEG recordings were obtained in all patients. Patients were 
selected for the study for whom both scans were obtained for the same ictal state (i.e. either both 
scans were interictal [n=7] or both scans were ictal/periictal [n=4]) and for whom the 
antiepileptic treatment was identical during both scans.   
PET scanning protocol 
 Patients were fasted for four hours prior to the PET studies.  Scalp EEG electrodes were 
placed according to the International 10-20 system, and EEG was monitored throughout the 
tracer uptake period. A venous line was established for injection of FDG (0.143 mCi/kg) 
produced using a Siemens RDS-11 cyclotron (Knoxville, Tennessee, USA).  
FDG PET studies were performed using a CTI/Siemens EXACT/HR whole body 
positron tomograph (Knoxville, Tennessee, USA).  This scanner has a 15 cm field of view and 
generates 47 image planes with a slice thickness of 3.125 mm.  The reconstructed image in-plane 
resolution obtained is 6.5 + 0.35 mm at full-width-at-half-maximum (FWHM) and 6.0 + 0.49 
mm in the axial direction for the FDG PET (reconstruction parameters: Shepp-Logan filter with 
1.1 cycles/cm cutoff frequency and Hanning filter with 0.20 cycles/pixel cutoff frequency).  
MRI/MRS data acquisition  
 MRI and MRS exams were performed on a GE 1.5 Tesla Signa 5.7 unit (GE Medical 
Systems, Milwaukee, Wisconsin, USA). Multiplanar MRI sequences were obtained in all cases 
including a 124 slice (1.5mm) T1 weighted spoiled gradient echo (SPGR), fluid-attenuated 
inversion-recovery (FLAIR) and a 21 plane axial T2 weighted sequences.  
 During 1H MRS examination a Stimulated Echo Acquisition Mode (STEAM) pulse 
sequence was used to acquire spectra using the following acquisition parameters and also 
included unsuppressed water reference scans for neurochemical quantitation: an echo time of 30 
msec, a modulation time of 13.7 msec, a repetition time of 2 sec, 8 step phase cycle, 2048 points, 
a spectral width of 2500 Hz, and 128 averages for a total acquisition time of approximately 5 
minutes. In vivo spectra were acquired from approximately 8cc volumes of interest (VOIs) in the 
region of the seizure focus and symmetrically on the contralateral side such that they contained 
almost entirely gray matter and did not contain structural lesions, if present.  
MRI/PET coregistration  
 Coregistration of FDG PET and MRI image volumes was performed using a multi-
purpose three-dimensional registration technique (MPItool). The PET image volume was 
coregistered with the axial MRI image volume using MPItool and a new image volume was 
created with 21 image planes corresponding to the original MRI image planes. Brain regions of 
interest (ROIs) for the position of the MRS voxels were registered on the axial T2 MRI images 
and then transferred to the coregistered FDG PET images. 
Visual PET image analysis 
 The PET scans were evaluated visually, and areas that were designated as having 
abnormal glucose metabolism were recorded. 
Quantitative PET image analysis  
 Regional values for tracer concentration were obtained by taking the average value for all 
planes in which the voxel was located. Regional values were then normalized to the 
concentration for the normal hemisphere (contralateral to the seizure focus), yielding a ratio of 
relative regional cerebral glucose utilization (rCGU). For the assessment of asymmetries in 
glucose metabolism, an asymmetry index (AI) was used: 
    AI (%) = (AC-AI)/[(AC+AI)/2] x 100 (%)  
where AI and AC are the radioactivity concentrations (µCi/ml) for the defined brain regions on 
the side of the seizure focus and contralateral to the focus, respectively. 
Quantitative MRS analysis  
 Compounds, which were identified in short echo 1H MRS human brain studies, included 
NA, Glx, Cr, Cho, and myo-Inositol (mI); however, the mI concentration values were not 
evaluated in this study. The area under each of the resonances is proportional to the 
concentration of the specific neurochemical compound. Individual peak areas were fit using time 
domain analysis software, and the concentrations of each compound are reported in arbitrary 
quantitative units as a ratio to brain water concentration (x104/water). The chemical shift values 
are 2.02 ppm for NA, 2.3 for the Glx complex, 3.03 ppm for Cr, 3.22 for Cho, and 3.56 for mI 
based on literature values. The resonance of NA contains overlapping resonances including 
predominantly NAA, as well as NAAG in smaller proportion. The Glx resonance typically 
contains approximately equal amounts of glutamate and glutamine, with a broader underlying 
macromolecule component and a relatively small contribution from GABA. However, with the 
acquisition parameters used in this study, the relative MR visibility of neurochemicals in the Glx 
resonance is more heavily weighted toward glutamate than glutamine because of relaxation and 
modulation effects (conservatively, a 60-to-40 ratio). 
Statistical analysis  
  A Pearson’s correlation was used to assess the correlation between the absolute values 
for NA and Glx values, as well as for Glx and relative rCGU values.  
 
RESULTS 
 
Tissue concentrations of brain metabolites 
 Decreased NA and Glx concentrations on the side of the seizure focus relative to the 
contralateral side were found in all seven patients with interictal studies. Four patients with 
ictal/periictal studies had higher NA and Glx concentrations on the side of the epileptic focus. 
The NA and Glx quantitative values showed correct focus (as determined by intracranial 
and/or scalp EEG) lateralization in each case, while it was shown by the NA/Cr, and the NA/Cho 
metabolite ratios only in eight patients. The lateralization value of these ratios was correct in all 
cases when the metabolites were registered from brain regions with at least 11% FDG PET 
asymmetry. 
 
Regional brain glucose utilization 
Various portions of the cortex and subcortical structures appeared normal by visual 
analysis; however, other parts of the brain showed abnormal glucose metabolism. The PET 
images revealed decreased regional cortical glucose metabolism on the side of seizure focus in all 
patients with interictal study, while PET images, obtained during ictal/periictal state, showed 
increased regional glucose metabolism corresponding to the side of EEG focus.  
Quantitative analysis of rCGU for the region of the seizure focus showed a broad range 
of values, varying from a decrease of 23.8% to an increase of 16.9% compared to the 
contralateral homotopic normal region. Decreased glucose metabolism was found in the seizure 
focus in all patients examined in the interictal states, while increased metabolism was observed 
in patients who had ictal/periictal studies.  The rCGU values showed correct focus lateralization 
in all examined patients including both the interictal and ictal/periictal studies. 
 
Relation between NA and Glx concentrations 
 A significant correlation was found in the comparison of tissue concentration of NA with 
concentration of Glx using ROIs in the epileptic cortex (r=0.60, p=0.048), while using 
contralateral homotopic ROIs, there was a tendency for statistical significant correlation (r=0.58, 
p=0.061). 
 
Relation between rCGU values and Glx concentrations 
 Significant correlations were found in the comparison of glucose metabolism with tissue 
concentration of glutamate/glutamine using ROIs in the epileptic cortex (r=0.67, p=0.021), using 
contralateral homotopic ROIs (r=0.60, p=0.047), and using the combined ROIs from focus and 
non-focus regions (r=0.64, p=0.0009). 
 
DISCUSSION 
 
In this study, brain metabolite concentrations of NA, Cr, Cho, Glx and cortical glucose 
metabolism were investigated in humans under normal and pathological conditions by 1H MRS 
and FDG PET in symmetrical brain regions. In order to compare the focus side to the non-focus 
side, one of the basic requirements of this study was to identify VOIs that contain predominantly 
gray matter, since brain metabolite concentrations, as well as glucose metabolism are different in 
gray and white matter.    
 
1H MRS measurements in focal epilepsy 
 The interictal results are consistent with the findings of previous MRS studies performed 
in patients with temporal and extratemporal lobe epilepsy showing reduction of NAA signal and 
decreased NAA/Cho and NAA/Cr ratios ipsilateral to the focus. In pathological states, decreases 
in the levels of NAA, NAAG, and in the activity of NAAG peptidase have been found correlating 
with neuronal loss. Normalization of decreased NAA after epilepsy surgery has been shown 
including both the ipsi and contralateral side. Thus, the reversible decrease of NAA concentration 
may represent decreased production due to neuronal and/or mitochondrial dysfunction, or 
degradation of NAA following neuronal membrane disruption. In contrast, larger diversity has 
been shown in NAA levels by ictal and postictal MRS studies, probably due to the differences in 
timing of scanning and acquisition after the seizure onset. In human studies, the values of 
NAA/Chol and NAA/Cr ratios were decreased in the ipsilateral temporal lobe; however, the 
majority of observations were made in the postictal period. In animal models, increased NA/Cr 
ratios were found in ictal state, while significant NAA changes were not observed postictally. 
The increased NA/Cr ratios have been considered to be a reflection of NAA synthesis increases, 
since negligible change in brain Cr levels has been shown under different pathologic conditions. 
Our data showing decreased Glx concentration interictally and increased concentration 
with seizure activity are consistent with previous findings. Lower Glx concentration has been 
shown ipsilateral to seizure onset in patients with temporal lobe epilepsy and hippocampal 
sclerosis as compared to normal controls. Enhanced glutamate release, contributing to the 
initiation of seizure activity, has been reported in microdialysis studies during seizures in 
patients with partial epilepsy, as well as in some animal models. Increased glutamate/glutamine 
level was also measured with MRS after status epilepticus in one patient with focal epilepsy. 
These data suggest that Glx concentration is lower in epileptogenic brain regions than in normal 
tissue, but may increase with ictal activity. The mechanism for a rapid increase in total tissue 
Glx during seizure activity, however, is unclear. The increase may be the result of increased flux 
through the glutamate/glutamine synthesis cycle. Another possible mechanism, which might 
contribute to a rapid increase in total tissue glutamate, could be the release of glutamate through 
the cleavage of NAAG.  NAAG is released by neuronal depolarization and is converted to NAA 
and glutamate by glutamate carboxypeptidase II, an enzyme present on the extracellular surface 
of glia and neurons. Alterations in NAAG and the carboxypeptidase activity have been reported 
in several animal models of epilepsy. In genetically epilepsy-prone rats, the activity of this 
membrane bound enzyme is increased in several brain regions, which increases the availability 
of NAA and glutamate in certain synapses of the brain. Kindling-induced increased NAAG level 
was observed in the entorhinal cortex.  Furthermore, the rapid turnover of NAAG shows that the 
conversion of NAA to NAAG can be an important modulator of synaptic activity.  
 
FDG PET measurements in focal epilepsy 
The characteristic of an epileptogenic focus, studied interictally in lesional and 
nonlesional neocortical epilepsy, is an area surrounded by large areas of reduced glucose 
metabolism which is usually larger than the pathological abnormality. The most likely reason for 
the large region of reduced metabolism is the inhibition or deafferentation of neurons around an 
epileptogenic focus. Partial seizures are associated with an increase in regional cerebral glucose 
metabolism in the region of the epileptogenic focus. Hypermetabolic areas have also been found 
in children with partial seizures, who did not have overt seizures and in patients with cryptogenic 
temporal lobe epilepsy who had never recieved antiepileptic drugs. The biochemical basis of 
interictal and ictal hypermetabolism is probably related to increased energy consumption by an 
active epileptogenic focus.  
 Lateralization of seizure focus 
1H spectroscopic imaging of brain metabolites and FDG PET have been proven to be a 
sensitive indicator for the lateralization of seizure foci in focal epilepsies; however, previous 
studies showed different concordance between the distribution of 1H MRS, FDG PET and EEG 
abnormalities. The sensitivity of 1H MRS in lateralization of unilateral temporal and 
extratemporal lobe epilepsy varied between 55-88% showing bilateral abnormalities in less than 
50% of the patients. These results were based on calculations of NAA/Cr, NAA/Cho and 
NAA/(Cr+Cho) metabolite ratios. Interictal FDG PET studies in patients with longstanding 
epilepsy predicted the side of the focus in almost all cases, though patients with recent-onset 
epilepsy appeared to have less intense metabolic abnormalities. In this study, the lateralization of 
epilepsy foci was precisely confirmed by quantitative values of NA, Glx and rCGU, while on the 
basis of the NA/Cr and NA/Cho metabolite ratios just partly. The lateralization value of 
metabolite ratios was higher in those patients having had voxels localized to areas with more 
intense abnormalities in cortical glucose metabolism. Interictally, the decreased metabolite ratios 
can be due to decreases of NA concentrations and/or increases of Cr and Cho concentrations. 
Intensive metabolic abnormalities are associated with profound neuronal dysfunction causing 
changes in the signal intensity of NAA. The concentrations of Cr and Cho appear to be much 
higher in oligodendrocytes and astrocytes than in neurons, thus the increased signal from these 
compounds may reflect gliosis or consistent with reactive astrocytosis. Conversely, there are 
several interictal studies with no significant changes in Cr and Cho levels. According to these 
observations, it is very likely that in those cases when gliosis or reactive astrocytosis are not 
present in epileptogenic brain tissue, the seizure focus lateralization is more precise by 
quantitative values than metabolite ratios. 
 
Relation between NA and Glx tissue concentrations 
    NAA and glutamate could be derived from many possible sources including the synaptic 
release of NAAG. NAAG has been linked to seizure disorder by kindling-induced increases of 
NAAG concentrations in entorhinal cortex. These increases proved to be persistent for at least 
one week. In conditions associated with increased excitability, the activity of NAAG peptidase 
can be elevated increasing the availability of NAA and glutamate in certain synapses of the brain 
leading to an excess of NAA uptake to oligodendrocytes and glutamate uptake into astrocytes. 
Further consequences of these processes are NAA hydrolysis and glutamine synthesis. Thus, it is 
likely that change in the balance of synthesis/release/catabolism of NAAG may play an important 
role in epileptic activity. In addition, conditions which increase the level of acetyl-CoA may 
significantly increase the synthesis of NAA. Increases in NAA levels may associate with 
increases in glutamate levels, since it appears that most of the NAA-derived [15N]aspartate 
undergoes transamination resulting in the formation of [15N]glutamate. 
 
Relation between glucose metabolism and glutamate/glutamine concentrations 
By combining FDG PET with 1H MRS, it is possible to study the relationship between 
cortical glucose metabolism and glutamate/glutamine concentration in humans under normal and 
different ictal conditions. Using this approach, we found a positive linear correlation between 
cortical glucose utilization and the glutamate/glutamine concentration. Glutamate uptake into the 
astrocytes by a glutamate transporter resulted in a concomitant stimulation of glucose uptake via 
a mechanism involving activation of the Na+/K+ ATPase, followed by an increase in lactate 
efflux from the astrocytes. Thus, this mechanism accounts for the coupling between neuronal 
activity and energy metabolism.  
  
SUMMARY AND NOVEL FINDINGS 
 
 In conclusion, both 1H MRS and FDG PET proved to be a useful diagnostic tool in the 
evaluation of partial epilepsies in vivo. To my best knowledge, this is the first investigation in 
which brain metabolites and glucose metabolism were studied in the same EEG defined epileptic 
foci during the same ictal sates. The cortical seizure focus can be characterized by lower NA and 
Glx concentrations, in addition to decreased glucose metabolism interictally, and by higher 
metabolite levels and increased glucose utilization in ictal state. The NA and Glx quantitative 
values of 1H MRS studies and the rCGU values of FDG PET studies showed higher sensitivity in 
focus lateralization than the NA/Cr and NA/Cho metabolite ratios. Furthermore, these results 
demonstrate a significant relationship between tissue glutamate/glutamine and NAA/NAAG 
concentrations in the epileptic cortex. Finally, the calculated data support the coupling of 
glucose metabolism to glutamate metabolism in the cerebral cortex, and extend previous 
findings to humans under normal and pathological conditions.  
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